enVVeno Medical receives Nasdaq bid-price deficiency notice; cure period to April 2026

enVVeno Medical Corp

Nasdaq notified enVVeno on Oct 7, 2025 that bid price closed below $1.00 for 30 consecutive business days.
Company has until April 6, 2026 to regain compliance by closing at or above $1.00 for 10 consecutive trading days.
If unmet, may seek 180-day extension by meeting other listing standards and committing to reverse stock split.
No immediate effect on listing; stock remains on Nasdaq Capital Market pending cure or appeal.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.